LH
Labcorp Holdings Inc.
Diagnostics & Research · Healthcare · United States
368.16
close · 2026-10-29
value
91
cheaper than peers91
quality
40
stronger fundamentals40
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 18.81× | 93 |
| EV to EBITDA | 14.46× | 85 |
| price to sales | 2.04× | 82 |
| price to book | 3.38× | 64 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 11.7% | 67 |
| operating margin | 12.2% | 58 |
| debt to equity | 79.1% | 36 |
| revenue growth | 5.8% | 27 |
4 of 4 measures available
Facts
| market cap | $30B |
| free cash flow | $892.0M |
| employees | 71,000 |
| first trade | 1990-03-29 |
| next earnings | 2026-10-28 |
| fundamentals updated | 2026-10-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 10.46 | 8.84 | 4.77 | 13.97 |
| free cash flow | $1.21B | $1.10B | $874.1M | $1.53B |
| net income | $876.5M | $746.0M | $418.0M | $1.28B |
| revenue | $13.95B | $13.01B | $12.16B | $11.86B |
| unusual items | -$116.3M | -$29.0M | -$369.3M | -$308.2M |